학술논문
Impact of baseline tumor burden on overall survival in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib in the SELECT global phase 3 trial
Document Type
Article
Author
Source
In: Cancer . (Cancer, 15 June 2022, 128(12):2281-2287)
Subject
Language
English
ISSN
10970142
0008543X
0008543X